Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal midazolam vs fentanyl vs magnesium sulfate with bupivacaine in knee arthroplasty
IRCT20141209020258N164Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Midazolam + bupivacaine, Fentanyl + bupivacaine and Magnesium sulfate + bupivacaine (3 arms). Primary endpoints: Duration of sensory block, Duration of motor block and 4 more. Started Apr 2021; status: completed.
02
Drugs
midazolamfentanylmagnesium sulfatebupivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20141209020258N164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N164.